EC Number   |
Disease |
PubMed ID |
Title of Publication  |
Category |
Confidence Level |
|---|
    4.1.3.16 | Hyperoxaluria, Primary |
22771891 |
4-Hydroxy-2-oxoglutarate aldolase inactivity in primary hyperoxaluria type 3 and glyoxylate reductase inhibition. |
diagnostic usage
unassigned |
2
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
27096395 |
Cellular degradation of 4-hydroxy-2-oxoglutarate aldolase leads to absolute deficiency in primary hyperoxaluria type 3. |
causal interaction
unassigned |
4
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
33543760 |
Clinical characterization of primary hyperoxaluria type 3 in comparison to types 1 and 2: a retrospective cohort study. |
causal interaction
unassigned |
4
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
28271480 |
Dihydrodipicolinate Synthase: Structure, Dynamics, Function, and Evolution. |
therapeutic application
unassigned |
3
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
29071511 |
Folding Defects Leading to Primary Hyperoxaluria. |
therapeutic application
unassigned |
1
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
27561601 |
HOGA1 Gene Mutations of Primary Hyperoxaluria Type 3 in Tunisian Patients. |
causal interaction
diagnostic usage
unassigned |
4
1
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
26428388 |
Hydroxyproline metabolism in a mouse model of Primary Hyperoxaluria Type 3. |
causal interaction
therapeutic application
unassigned |
4
1
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
31401635 |
Mutation Hot Spot Region in the HOGA1 Gene Associated with Primary Hyperoxaluria Type 3 in the Chinese Population. |
unassigned |
0 |
| 4.1.3.16 | Hyperoxaluria, Primary |
20797690 |
Mutations in DHDPSL are responsible for primary hyperoxaluria type III. |
causal interaction
unassigned |
3
0 |
| 4.1.3.16 | Hyperoxaluria |
33350326 |
Mutations in HOGA1 do Not Confer a Dominant Phenotype Manifesting as Kidney Stone Disease. |
causal interaction
ongoing research
unassigned |
4
3
0 |
